Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze-Reference-Cited by-同舟云学术

Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze

Published:2004-05 Issue:1-3 Volume:361 Page:128-131
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Alcalay Roy N.,Giladi Eliezer,Pick Chaim G.,Gozes Illana

Publisher

Elsevier BV

Subject

General Neuroscience

Reference20 articles.

1. The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders;Andrieux;Genes Dev.,2002

2. Complete sequence of a novel protein containing a femtomolar activity dependent neuroprotective peptide;Bassan;J. Neurochem.,1999

3. Measuring normal and pathological anxiety like behaviour in mice: a review;Belzung;Behav. Brain Res.,2001

4. A peptide derived from activity dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice;Beni Adani;J. Pharmacol. Exp. Ther.,2001

5. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities and specific behavioral tests;Crawley;Brain Res.,1999

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mix of almond baru (Dipteryx alata Vog.) and goat whey modulated intestinal microbiota, improved memory and induced anxiolytic like behavior in aged rats;Journal of Psychiatric Research;2023-08

2. Intranasal Peptide Therapeutics: A Promising Avenue for Overcoming the Challenges of Traditional CNS Drug Development;Cells;2022-11-16

3. SH3- and actin-binding domains connect ADNP and SHANK3, revealing a fundamental shared mechanism underlying autism;Molecular Psychiatry;2022-05-10

4. Direct Delivery of ANA-TA9, a Peptide Capable of Aβ Hydrolysis, to the Brain by Intranasal Administration;Pharmaceutics;2021-10-13

5. Advances in Stem Cell Therapy for Brain Diseases via the Intranasal Route;Current Pharmaceutical Biotechnology;2021-08-03